This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Noedl, H.
Right arrow Articles by Wongsrichanalai, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Noedl, H.
Right arrow Articles by Wongsrichanalai, C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2002, p. 1658-1664, Vol. 46, No. 6
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.6.1658-1664.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Histidine-Rich Protein II: a Novel Approach to Malaria Drug Sensitivity Testing

Harald Noedl,1,2* Walther H. Wernsdorfer,2 Robert Scott Miller,1 and Chansuda Wongsrichanalai1

Department of Immunology and Medicine, Armed Forces Research Institute of Medical Sciences (USAMC-AFRIMS), Bangkok, Thailand,1 Department of Specific Prophylaxis and Tropical Medicine, Institute of Pathophysiology, University of Vienna, Vienna, Austria2

Received 7 January 2002/ Returned for modification 8 February 2002/ Accepted 27 February 2002

The production of histidine-rich protein II (HRP2), a histidine- and alanine-rich protein produced by Plasmodium falciparum, is closely associated with the development and proliferation of the parasite and therefore is perfectly suited to reflect growth inhibition as a measure of drug susceptibility. It was the aim of the present study to develop a malaria drug sensitivity assay based on the measurement of HRP2 in a simple enzyme-linked immunosorbent assay (ELISA). The new test proved to be as reliable as traditional in vitro assays, while it was considerably easier to establish and perform. Parasites are incubated at an initial level of parasitemia of 0.01 to 0.1% on microculture plates predosed with ascending concentrations of antimalarial drugs. After incubation for 48 to 72 h, the samples are freeze-thawed and transferred to ELISA plates. The complete ELISA takes about 2.5 h to perform, may be carried out with commercially available test kits, and requires relatively little technical equipment. In correlation analysis, the results closely paralleled those obtained by the isotopic assay (R = 0.892; P < 0.0001) and World Health Organization schizont maturation tests (R = 0.959; P < 0.0001). The novel HRP2 drug susceptibility assay proved to be very sensitive, simple to establish, and highly reproducible. It can be used for a wide range of applications, from epidemiological studies to the screening of new drugs, and may have the potential to replace traditional in vitro techniques. Standard operating procedures, updated information, and analytical software are available from http://malaria.farch.net.

* Corresponding author. Mailing address: Department of Specific Prophylaxis and Tropical Medicine, Institute of Pathophysiology, University of Vienna, Kinderspitalgasse 15, A-1095 Vienna, Austria. Phone: 43-1-40204 80. Fax: 43-1-403 83 43 90. E-mail: harald.noedl{at}univie.ac.at.

Antimicrobial Agents and Chemotherapy, June 2002, p. 1658-1664, Vol. 46, No. 6
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.6.1658-1664.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Starzengruber, P., Thriemer, K., Haque, R., Khan, W. A., Fuehrer, H. P., Siedl, A., Hofecker, V., Ley, B., Wernsdorfer, W. H., Noedl, H. (2009). Antimalarial Activity of Tigecycline, a Novel Glycylcycline Antibiotic. Antimicrob. Agents Chemother. 53: 4040-4042 [Abstract] [Full Text]  
  • Jia, H., Terkawi, M. A., Aboge, G. O., Goo, Y.-K., Ma, L., Zhou, J., Nishikawa, Y., Igarashi, I., Fujisaki, K., Xuan, X. (2009). Identification of Secreted Antigen 3 from Babesia gibsoni. CVI 16: 944-948 [Abstract] [Full Text]  
  • Martin, S. K., Rajasekariah, G-H., Awinda, G., Waitumbi, J., Kifude, C. (2009). Unified Parasite Lactate Dehydrogenase and Histidine-Rich Protein ELISA for Quantification of Plasmodium falciparum. Am J Trop Med Hyg 80: 516-522 [Abstract] [Full Text]  
  • Liu, S., Mu, J., Jiang, H., Su, X.-z. (2008). Effects of Plasmodium falciparum Mixed Infections on In Vitro Antimalarial Drug Tests and Genotyping. Am J Trop Med Hyg 79: 178-184 [Abstract] [Full Text]  
  • Kifude, C. M., Rajasekariah, H. G., Sullivan, D. J. Jr., Stewart, V. A., Angov, E., Martin, S. K., Diggs, C. L., Waitumbi, J. N. (2008). Enzyme-Linked Immunosorbent Assay for Detection of Plasmodium falciparum Histidine-Rich Protein 2 in Blood, Plasma, and Serum. CVI 15: 1012-1018 [Abstract] [Full Text]  
  • Wilson, N. O., Adjei, A. A., Anderson, W., Baidoo, S., Stiles, J. K. (2008). Detection of Plasmodium falciparum Histidine-rich Protein II in Saliva of Malaria Patients. Am J Trop Med Hyg 78: 733-735 [Abstract] [Full Text]  
  • Houze, S., Munier, A., Paoletti, X., Kaddouri, H., Ringwald, P., Le Bras, J. (2007). Shelf Life of Predosed Plates Containing Mefloquine, Artemisinin, Dihydroartemisinin, and Artesunate as Used for In Vitro Plasmodium falciparum Susceptibility Assessment. J. Clin. Microbiol. 45: 2734-2736 [Abstract] [Full Text]  
  • Johnson, J. D., Dennull, R. A., Gerena, L., Lopez-Sanchez, M., Roncal, N. E., Waters, N. C. (2007). Assessment and Continued Validation of the Malaria SYBR Green I-Based Fluorescence Assay for Use in Malaria Drug Screening. Antimicrob. Agents Chemother. 51: 1926-1933 [Abstract] [Full Text]  
  • Bacon, D. J., Latour, C., Lucas, C., Colina, O., Ringwald, P., Picot, S. (2007). Comparison of a SYBR Green I-Based Assay with a Histidine-Rich Protein II Enzyme-Linked Immunosorbent Assay for In Vitro Antimalarial Drug Efficacy Testing and Application to Clinical Isolates. Antimicrob. Agents Chemother. 51: 1172-1178 [Abstract] [Full Text]  
  • KREIDENWEISS, A., KREMSNER, P. G., DIETZ, K., MORDMULLER, B. (2006). IN VITRO ACTIVITY OF FERROQUINE (SAR97193) IS INDEPENDENT OF CHLOROQUINE RESISTANCE IN PLASMODIUM FALCIPARUM. Am J Trop Med Hyg 75: 1178-1181 [Abstract] [Full Text]  
  • JIA, H., ZHOU, J., IKADAI, H., MATSUU, A., SUZUKI, H., IGARASHI, I., FUJISAKI, K., XUAN, X. (2006). IDENTIFICATION OF A NOVEL GENE ENCODING A SECRETED ANTIGEN 1 OF BABESIA GIBSONI AND EVALUATION OF ITS USE IN SERODIAGNOSIS. Am J Trop Med Hyg 75: 843-850 [Abstract] [Full Text]  
  • Kaddouri, H., Nakache, S., Houze, S., Mentre, F., Le Bras, J. (2006). Assessment of the Drug Susceptibility of Plasmodium falciparum Clinical Isolates from Africa by Using a Plasmodium Lactate Dehydrogenase Immunodetection Assay and an Inhibitory Maximum Effect Model for Precise Measurement of the 50-Percent Inhibitory Concentration. Antimicrob. Agents Chemother. 50: 3343-3349 [Abstract] [Full Text]  
  • RAMHARTER, M., BURKHARDT, D., NEMETH, J., ADEGNIKA, A. A., KREMSNER, P. G. (2006). IN VITRO ACTIVITY OF ARTEMISONE COMPARED WITH ARTESUNATE AGAINST PLASMODIUM FALCIPARUM.. Am J Trop Med Hyg 75: 637-639 [Abstract] [Full Text]  
  • THRIEMER, K., HAQUE, R., WAGATSUMA, Y., SALAM, M. A., AKTHER, S., ATTLMAYR, B., FUKUDA, M., SCHAECHER, K., MILLER, R. S., NOEDL, H. (2006). THERAPEUTIC EFFICACY OF QUININE PLUS SULFADOXINE-PYREMETHAMINE FOR THE TREATMENT OF UNCOMPLICATED FALCIPARUM MALARIA IN BANGLADESH.. Am J Trop Med Hyg 75: 645-649 [Abstract] [Full Text]  
  • Noedl, H., Bronnert, J., Yingyuen, K., Attlmayr, B., Kollaritsch, H., Fukuda, M. (2005). Simple Histidine-Rich Protein 2 Double-Site Sandwich Enzyme-Linked Immunosorbent Assay for Use in Malaria Drug Sensitivity Testing. Antimicrob. Agents Chemother. 49: 3575-3577 [Abstract] [Full Text]  
  • NOEDL, H., ATTLMAYR, B., WERNSDORFER, W. H., KOLLARITSCH, H., MILLER, R. S. (2004). A HISTIDINE-RICH PROTEIN 2-BASED MALARIA DRUG SENSITIVITY ASSAY FOR FIELD USE. Am J Trop Med Hyg 71: 711-714 [Abstract] [Full Text]  
  • Noedl, H., Teja-Isavadharm, P., Miller, R. S. (2004). Nonisotopic, Semiautomated Plasmodium falciparum Bioassay for Measurement of Antimalarial Drug Levels in Serum or Plasma. Antimicrob. Agents Chemother. 48: 4485-4487 [Abstract] [Full Text]  
  • BASCO, L. K. (2004). MOLECULAR EPIDEMIOLOGY OF MALARIA IN CAMEROON. XX. EXPERIMENTAL STUDIES ON VARIOUS FACTORS OF IN VITRO DRUG SENSITIVITY ASSAYS USING FRESH ISOLATES OF PLASMODIUM FALCIPARUM. Am J Trop Med Hyg 70: 474-480 [Abstract] [Full Text]  
  • Talisuna, A. O., Bloland, P., D'Alessandro, U. (2004). History, Dynamics, and Public Health Importance of Malaria Parasite Resistance. Clin. Microbiol. Rev. 17: 235-254 [Abstract] [Full Text]  
  • Ramharter, M., Noedl, H., Winkler, H., Graninger, W., Wernsdorfer, W. H., Kremsner, P. G., Winkler, S. (2003). In Vitro Activity and Interaction of Clindamycin Combined with Dihydroartemisinin against Plasmodium falciparum. Antimicrob. Agents Chemother. 47: 3494-3499 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»